105.00SEK0.00%Mkt Cap: 14.09B SEKP/E: —Last update: 2026-05-13
Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)21.62
PEG2.02
P/B1.75
P/S4.14
EV/EBITDA15.79
EV/Revenue4.34
EPS (TTM)-37.01
EPS (Forward)4.81
Cash Flow & Leverage
FCF Yield3.75%
FCF Margin15.50%
Operating CF635.00M SEK
CapEx (TTM)247.00M SEK
Net Debt/EBITDA0.74
Net Debt696.00M SEK
Technical
SMA 5099.93 (+5.1%)
SMA 200122.20 (-14.1%)
Beta1.73
S&P 52W Chg24.23%
Avg Vol (30d)237.85K
Avg Vol (10d)103.58K
Technical Indicators
RSI (14)49.6
MACD1.7246
MACD Signal2.7186
MACD Hist.-0.9941
BB Upper116.60 SEK
BB Middle108.82 SEK
BB Lower101.04 SEK
BB Width14.29%
ATR (14)3.686 SEK
Vol Ratio (20d)0.59x
52W Range
84.6026% of range163.10
52W High163.10 SEK
52W Low84.60 SEK
Profitability
Gross Margin58.05%
EBITDA Margin27.49%
Profit Margin-145.70%
Oper. Margin18.46%
ROE-63.49%
ROA-45.06%
Revenue Growth-4.20%
Earnings Growth0.20%
Balance Sheet
Debt/Equity0.20
Current Ratio3.68
Quick Ratio2.83
Book Value/Sh59.58 SEK
Cash/Share6.542 SEK
Dividends
Fwd Div Rate1.100 SEK
Trail. Div Rate1.100 SEK
Div. Yield1.06%
5Y Avg Yield0.49%
Payout Ratio33.85%
Ex-Div DateMay 6, 2026
Pay Date—
Splits
Last Split5:1
Split DateMay 17, 2018
Ownership
Shares Out.135.45M
Float73.71M
Insiders28.73%
Institutions65.79%
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)172.20 SEK
Target Range131.00 SEK – 215.00 SEK
# Analysts5
Company
Market Cap14.09B SEK
Enterprise Value14.78B SEK
Revenue (TTM)3.40B SEK
Gross Profit2.00B SEK
Net Income (TTM)-5.01B SEK
Revenue/Share25.14 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.1K
Last Price105.00 SEK
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0011205202